Zona pellucida (ZP) glycoproteins are promising candidate antigens for use in immunocontraceptive vaccines because of their crucial role in mammalian fertilization. A single intraperitoneal immunization with recombinant murine cytomegalovirus engineered to express murine ZP3 (rMCMVmZP3) induces permanent infertility with no evident systemic illness in female BALB/c mice. To investigate the mechanisms underpinning reproductive failure elicited by rMCMV-mZP3, ovarian parameters and reproductive function were evaluated at time points spanning 10 days to 5 wk after virus inoculation. Fertility was substantially impaired by 14 days after inoculation with rMCMV-mZP3 and was fully ablated by 21 days. Pregnancies established after inoculation but before complete infertility showed no adverse effects on fetal viability assessed at Day 17.5 post coitum (pc). Infertile mice retained estrous cycling activity and remained receptive to mating; however, at Day 3.5 pc there were fewer developing embryos and corpora lutea, plasma progesterone content was reduced, and there was no evidence of excess unfertilized oocytes. Consistent with this, profound ovarian pathology was evident from 10 days after rMCMV-mZP3 inoculation, with a decline first in mature ovarian follicles and then in immature ovarian follicles and with diminished expression of genes regulating follicle development, including Nobox, Gdf 9, and Gja1 (connexin43). Follicle loss was associated with mild focal oophoritis and with recruitment of inflammatory leukocytes, predominantly CD4 + and CD8 + T cells evident from 10 days after virus inoculation. These data indicate that vaccination with rMCMV-mZP3 causes permanent infertility in BALB/c mice principally due to induction of ovarian autoimmune pathology leading to progressive oocyte depletion and eventual ovulation failure.
INTRODUCTION
Effective immunocontraception requires the presentation of reproductive antigens in a target species to activate an antigenspecific immune response that subsequently disrupts one or more essential steps in the reproductive process without other adverse health effects. Candidate reproductive antigens are primarily sperm and oocyte proteins [1, 2] and include enzymes involved in steroidogenic pathways and reproductive hormones [2, 3] . The most effective antigens are the zona pellucida (ZP) proteins because of their critical role in oocyte fertilization. The ZP is a matrix that encapsulates the mammalian oocyte during follicular development and after ovulation and consists of three major sulphated glycoproteins known as ZP1, ZP2, and ZP3 [4] . In the mouse, sperm bind to the O-linked oligosaccharides on the mZP3 glycoprotein and then undergo an acrosome reaction enabling their penetration of the ZP and fusion with the oocyte plasma membrane [5] . The potential utility of ZP proteins for immunocontraception was identified in the late 1970s, when transient infertility was induced in mice after active immunization with hamster ZP proteins [6] . There is now evidence showing the efficacy of immunocontraceptive vaccines targeting native or recombinant ZP proteins, particularly ZP3, in rodent and primate models [7] . Strategies utilizing ZP3 have been applied in the development of vaccines for controlling pest animal species [8] , as well as potentially reversible contraception for women and domestic animal species [2] .
Vaccination with ZP3 is generally thought to induce infertility in the host due to antibodies produced after immunization that bind to the oocyte ZP and prevent spermzona interaction [9, 10] . Significant ovarian inflammation and pathology have also been reported and can contribute to infertility through follicle depletion, an adverse effect that may pose a serious impediment where reversibility and recovery of fertility are required [11, 12] . However, permanent ovarian dysfunction is acceptable when lifelong infertility is sought for biological control of pest animals such as mice, rabbits, and foxes [8] and when prevention of unintended effects in nontarget animal species and feasibility of vaccine delivery are of paramount concern. Therefore, recent research has concentrated on the development of live recombinant viral vectors to allow free dissemination in the wild environment, to improve antigen immunogenicity, and to provide host specificity [13, 14] .
Murine cytomegalovirus (MCMV) is an attractive viral vector for biological control of wild mice, which regularly undergo population eruptions in rural Australia [15] . It is a beta-herpesvirus containing a large, double-stranded DNA genome, which characteristically establishes a persistent and latent infection and is restricted in its host specificity [15, 16] . Murine cytomegalovirus engineered to express murine zona ZP 3 (rMCMV-mZP3) has been shown to induce lifelong sterility in laboratory and wild-derived mice [14, 17] . The efficacy of this vaccine in mice is attributed to the ability of MCMV to evade host immune clearance, establishing a persistent infection in the salivary glands after initial replication in the spleen, liver, and lungs [18] .
We have previously reported that immunization with rMCMV-mZP3 in BALB/c mice induces complete, long-term infertility extending past 100 days in all mice inoculated [14] . The mechanism of infertility was not identified, although persistent anti-ZP3 antibody production was evident, and histological examination of the ovaries revealed evidence of ovarian pathology [14] . The objectives of the present study were to undertake a detailed investigation of the pathophysiological mechanisms underpinning the immunocontraceptive effect of rMCMV-mZP3 in BALB/c mice. Experiments were designed to investigate the time course of fertility loss after rMCMV-mZP3 immunization and the nature of the resulting pathology, including the reproductive lesions explaining the resulting infertility. In particular, we sought to examine whether infertility could be attributed to effects on follicle development and ovulation, as opposed to oocyte fertilization. We report that intraperitoneal inoculation of BALB/c mice with rMCMV-mZP3 elicits complete infertility by Day 21 after inoculation. This is associated with substantial ovarian leukocyte infiltration and with diminished expression of genes encoding regulators of oocyte function and development, followed by depletion of ovarian follicles initially at the antral stage and subsequently at earlier stages of development. Although mice retain estrous cycling activity and receptivity to males, ovarian dysfunction is evidenced by reduced numbers of corpora lutea (CL), oocytes, and developing embryos present in the reproductive tract, as well as reduced progesterone production. These findings are consistent with an extensive ovarian autoimmune response leading to impaired follicular development, oocyte depletion, and ovulation failure as the major cause of infertility following ZP3 immunization.
MATERIALS AND METHODS

Mice
Specific pathogen-free BALB/c male and female mice were obtained from the Animal Resources Centre (Murdoch, Australia) or the University of Adelaide Central Animal House (Adelaide, Australia). All mice were housed under specific pathogen-free conditions on a 12L:12D cycle and were administered food and water ad libitum. Animal usage was in accord with The Australian Code of Practice for the Care and Use of Animals for Scientific Purposes and was approved by the University of Western Australia Animal Experimentation and Ethics Committee and the University of Adelaide Animal Ethics Committee.
Virus
The K181 strain of MCMV has been described previously [19] . Virus stocks were propagated in mouse embryonic fibroblast (MEF) cells [20] , and virus titres were determined in duplicate by plaque assay in MEF [14] . Recombinant MCMV was produced as described previously [14] by the insertion of the Zp3 gene encoding murine ZP3 into the nonessential ie2 region of K181 MCMV under the control of an HCMV IEI promoter (rMCMVmZP3). Control recombinant virus comprised native K181 (MCMV) or K181 containing the LOC396058 gene encoding chicken egg ovalbumin (rMCMV-OVA) [21] as specified. Recombinant virus stocks of rMCMV-mZP3 and rMCMV-OVA were proven to be fully competent for replication in MEF cells in vitro. All virus stocks were titrated to provide treatment doses of 2 3 10 4 plaque-forming units (pfu) in 0.1 ml of PBS.
Fertility Studies
Female mice at 8 wk of age were inoculated with 2 3 10 4 pfu of MCMV or rMCMV-mZP3 in 0.1 ml of PBS by i.p. injection and were housed in groups before placement with proven fertile stud males at a ratio of 1:1 (male:female) on Day 7, 14, or 21 after inoculation. Sham-inoculated female mice comprising a control group were injected i.p. with 0.1 ml of PBS and 7 days later were housed with stud males at a ratio of 1:1. Females were inspected daily for vaginal plugs indicative of a mating event. The day of vaginal plug detection was designated Day 0.5 post coitum (pc), when females were removed from the male and housed in groups of two to five. At Day 17.5 pc, females were killed by methoxyflurane anesthesia (Penthrox; Medical Developments International Ltd.), followed by cervical dislocation. The intact uterus from each female was removed, and total, viable, and resorbing implantation sites were counted. Each viable fetus was dissected from the amniotic sac and umbilical cord, and fetuses and placentae were weighed.
In a second fertility experiment, mice at 8 wk of age were injected i.p. with 0.1 ml of PBS or inoculated i.p. with 2 3 10 4 pfu of rMCMV-OVA or rMCMV-mZP3 in 0.1 ml of PBS as already described. Twenty-one days after inoculation, the female mice were housed with stud males at a ratio of 1:3 (male:female). Mated female mice were killed on Day 3.5 pc using 2% 2.2.2-tribromomethanol anesthesia (2% Avertin; Sigma-Aldrich), followed by cervical dislocation. Blood was collected by cardiac puncture for plasma progesterone assay. Reproductive tracts were removed, and embryos and unfertilized oocytes were flushed from the uterus and oviducts and were counted. The developmental stage of embryos was assessed visually using a dissecting microscope (Nikon SMZ800) and was scored as cleavage stage, morulla, early blastocyst, or degenerated embryos according to conventional criteria [22] . Ovaries were retrieved and placed in 4% paraformaldehyde solution (Sigma-Aldrich) for later counting of CL by visual inspection using a dissecting microscope (Nikon SMZ800).
Ovarian Studies
Mice at 8 wk of age were injected i.p. with 0.1 ml of PBS or inoculated i.p. with 2 3 10 4 pfu of MCMV or rMCMV-mZP3 in 0.1 ml of PBS. Ovarian tissue was retrieved on Days 10, 15, 21, and 35 after inoculation and trimmed of fat and connective tissue. Ovaries were immediately placed in RNAlater (Ambion) and stored at À208C for later RT-PCR analysis or were frozen in Optimal Cutting Temperature (OCT) compound (Sakura Finetek) using liquid nitrogencooled isopentane and stored at À808C for later histochemical or immunohistochemical analysis.
Histology and Quantification of Ovarian Follicles
Sections (7 lm) of whole ovaries embedded in OCT were cut with a Leica CM1850 cryostat (Leica Microsystems), stained with hematoxylin-eosin, cleared with Safsolvent (Ajax Chemicals), and mounted with DPX (BDH Laboratory Supplies) according to standard protocols. Every third section (21 lm apart) was examined microscopically under a 103 objective lens to identify pre-antral, antral, and preovulatory follicles and under a 403 objective lens to identify primary and secondary follicles. Morphological classification of healthy ovarian follicles was performed using criteria detailed previously [23] . Briefly, follicles classified as primary showed a single layer of cuboidal granulosa cells. Follicles with more than one layer of granulosa cells but no visible antrum were classified as secondary. Early antral follicles were characterized by the presence of one or two small areas of follicular fluid (antrums), while antral follicles contained a large antral space. Follicles were classified as preovulatory if they contained a distinct oocyte surrounded by cumulus cells. Primordial follicles and follicles undergoing atresia were not counted. Some additional ovaries recovered from mice at 21 and 35 days after inoculation were fixed in 4% paraformaldehyde solution for 24 h and then washed in four changes of PBS (pH 7.4) during 2 days and processed and embedded in paraffin. Transverse sections (5 lm) were cut from the medial region and stained with hematoxylin-eosin by standard techniques for histological analysis using an Olympus BH2 light microscope.
Immunohistochemistry
Sections (7 lm) of whole ovaries embedded in OCT were cut with a Leica CM1850 cryostat, placed on poly-L-lysine-coated slides (PolysineTM Microslides; Menzel-Glaser) and allowed to air dry. Dried sections were fixed in 96% ethanol for 10 min at 48C and then washed three times in 13 PBS. Sections were blocked with 1% BSA in PBS for 2 min and were then incubated with primary antibody diluted to 10 lg ml À1 in 10% normal mouse serum in PBS (PBS-NMS) for 2 h at 48C. Rat monoclonal antibodies reactive with murine CD45 (MCA1388) 850 were purchased from Serotec, and rat monoclonal antibodies reactive with murine CD4 (LS009) and CD8 (LS015) were purchased from Dakopatts. Sections were washed in PBS and incubated with biotinylated rabbit anti-rat immunoglobulin (Dakopatts) in PBS-NMS for 60 min at room temperature. Sections were then washed in PBS and incubated in horseradish peroxidase-conjugated streptavidin (Dakopatts) in PBS-NMS (30 min at room temperature). Bound antibody was visualized by incubating slides with 0.05% diaminobenzidine tetrahydrochloride (Sigma-Aldrich) in Tris-buffered saline containing 0.1% hydrogen peroxide (10 min at room temperature). Slides were counterstained with hematoxylin, dehydrated, cleared in Safsolvent, and mounted in DPX.
The number of stained leukocytes was quantified in 10 randomly selected fields using video image analysis with Video Pro software (Leading Edge Software) using a 103 objective and 3.33 photography eyepiece as previously described [24] . Data are expressed as percentage positivity, calculated as the mean area of diaminobenzidine stain as a percentage of the area of total stain in the 10 fields. Corpora lutea were excluded from the areas of ovarian tissue in which leukocytes were quantified. Repeated measurements of a single test field validated the precision of this method (,10% within-assay variation).
Quantitative RT-PCR
Complementary DNA was prepared from ovaries stored in RNAlater solution (Ambion) at À208C until processing. Total cellular RNA was extracted using RNAqueous-Micro kits (Ambion) according to the manufacturer's guidelines. Following treatment with RNase-free DNase I (500 IU ml À1 for 60 min at 378C) (Roche), first-strand cDNA was reverse transcribed from 1 lg of RNA using an Expand Reverse Transcriptase kit (10 min at 308C and then 45 min at 428C; Roche). The cDNA solution was diluted to 100 ll and stored atÀ208C. Primer pairs specific for published Genbank cDNA sequences of Nobox, Gdf 9, Gja1, and Actb (Table 1) were designed using Primer Express software (Applied Biosystems).
The PCR amplification used reagents supplied in a 23 SYBR Green PCR master mix (Applied Biosystems), and each reaction volume (20 ll total) contained 0.5-1.0 lM 5 0 and 3 0 primer and 3 ll of cDNA. The negative control included in each reaction consisted of water substituted for cDNA. The PCR amplification was performed in a Corbett Rotor-Gene 6000 (Corbett Life Science). The PCR primers and optimized PCR reaction conditions for each primer pair are listed in Table 1 . Cycle threshold values (Ct), defined as the cycle number at which the detected fluorescence exceeds the threshold value, were determined for serial 8-fold dilutions of cDNA in 0.06-30 ng of total RNA. For each primer pair, the linearity of detection was confirmed to have a correlation coefficient exceeding 0.94 over the detection range when plotted as Ct vs. the log of cDNA dilution. Validation experiments were performed to confirm the expected amplification efficiency of each primer pair, and primer specificity was confirmed by dissociation curve profile analysis of the reaction product. The expected size of reaction products was confirmed by electrophoresis in 2% agarose gel containing 0.5 lg ml À1 ethidium bromide, followed by visualization on a UV light box.
The Nobox, Gdf 9, and Gja1 cDNA content of experimental tissues was normalized to Actb cDNA and given as a percentage of the mean value for the PBS-inoculated group at each time point. Amplicons were quantified using the arithmetic equation 2 DCt 3 100 K À1 (Applied Biosystems User Bulletin 2), where K is the normalizing constant. A single ''relative mRNA expression'' value for each mRNA transcript of interest for each mouse was calculated as the mean of triplicate cDNA samples.
Plasma Progesterone
Blood collected by cardiac puncture was collected in 1-ml syringes previously coated with heparin sulphate (Sigma-Aldrich). Plasma was collected after centrifugation at 1200 3 g for 20 min and stored at À208C. The concentration of progesterone in 25 ll of plasma was assayed by radioimmunoassay (Diagnostic Systems Laboratories). The assay was performed per the manufacturer's recommendations, and values were obtained from a 1-60 ng/ml standard curve. The intraassay coefficient of variation was less than 10%.
Statistical Analysis
To assess differences in categorical data (pregnancy rate, embryo development, and resorption rate), chi-square tests were performed using Microsoft Excel. All other data were assessed using SPSS version 13.0 (SPSS Inc.). To assess differences in fetal and placental weights, linear mixed-model repeated-measures ANOVA with post hoc Bonferroni t-test were performed with the mother as the subject and the fetal or placental values as the repeated measure. The number of viable fetuses per litter was used as a covariate when required, and data are expressed as estimated marginal mean 6 SEM. Effects of treatments on reproductive and ovarian parameters were evaluated by oneway ANOVA, followed by Sidak t-test after confirmation of normal distribution of data by Shapiro-Wilk normality test. Messenger RNA expression data was not normally distributed and was analyzed using Kruskal-Wallis one-way ANOVA and Mann-Whitney U-test. The relationship between the number of CL and the plasma progesterone content was analyzed by bivariate correlation using Pearson correlation coefficient (R). Data were considered statistically significant at P , 0.05.
RESULTS
Kinetics of Infertility Induction after rMCMV-mZP3 Immunization
To determine the time taken to reach infertility after inoculation with rMCMV-mZP3, as well as the effect on reproductive outcomes during the interval before complete loss of fertility, female mice were housed with stud males at Days 7, 14, and 21 after inoculation with rMCMV-mZP3 or with MCMV virus control. The effect of virus inoculation on mating parameters was measured by daily examination for vaginal plugs, and the effect on reproductive outcome was evaluated by autopsy of mated mice at Day 17.5 pc. The reproductive performance of virus-inoculated mice was compared with that of a third group of mice sham-inoculated with PBS and placed with stud males 7 days later.
Female mice inoculated with MCMV virus control exhibited normal receptivity to males with no significant difference in the interval between housing with a male and observation of a vaginal plug or in the proportion of females mated within a 10-day period at any of the three time points (Table 2 ). There was no reduction in fertility in MCMVinoculated mice as measured by the proportion of mated mice with viable pregnancies at Day 17.5 pc (pregnancy rates, nine of 10 and 21 of 29 in the PBS and MCMV groups, respectively), despite a modest reduction in the pregnancy rate in mice mated 14 days after inoculation with MCMV (pregnancy rate, six of 10) (P , 0.05) (Fig. 1) . The numbers of implantation sites in pregnant females were not changed in In mice inoculated with rMCMV-mZP3, there was no change in receptivity to males. All females mated within the expected interval after placement with males irrespective of the interval since virus inoculation (Table 2) .
There was a significant reduction in the proportion of mice mated at Day 7 after inoculation that were pregnant at Day 17.5 pc and a progressive decline in fertility thereafter, with 60%, 20%, and 0% of plugged mice having viable pregnancies after mating at 7, 14, and 21 days after inoculation, respectively (Fig  1) . The number of implantation sites retrieved from pregnant females inoculated with rMCMV-mZP3 was not significantly different from that of MCMV or PBS controls in mice mated at Day 7 after inoculation but was substantially reduced when mice were mated at Day 14 after inoculation, with each of two pregnant mice having only one implantation site (P ¼ 0.048).
These data show that the fertility of rMCMV-mZP3-treated mice is essentially normal for 7 days after inoculation, is substantially reduced by 14 days, and is completely ablated by 21 days after inoculation. During the period before acquisition of complete infertility, the likelihood of a mating event resulting in pregnancy is substantially reduced, and pregnancies established in this interim period have fewer implantation sites. However, mice remain receptive to males and seem to retain normal estrous cycling activity, as evidenced by the expected interval between placement with males and the detection of a mating plug, even after complete infertility is achieved.
Effect of rMCMV-mZP3 Inoculation on Fetal Development
We also evaluated the fate of pregnancies established in virus-inoculated mice to investigate any possible adverse effects of virus infection or anti-ZP3 immunity on fetal or placental growth and fetal viability. Fetal development seemed to be largely unaffected in pregnancies established within the 3-wk period after inoculation with MCMV control virus or rMCMV-mZP3 compared with the PBS control group. Fetal loss in midgestation, as measured by the proportion of fetuses undergoing resorption at Day 17.5 pc, was not increased in pregnancies established by mating at Day 7, 14, or 21 after inoculation in either virus treatment group (Table 2) .
Fetal development was also assessed by measuring fetal and placental weights. Inoculation with MCMV control virus led to a decrease of approximately 10% in fetal weight in pregnancies conceived at Day 7 after inoculation (mean [SEM], 1100 6 20 mg in the PBS group vs. 997 6 20 mg in the MCMV group; P ¼ 0.026). A similar effect of rMCMV-mZP3 inoculation was seen (mean [SEM], 976 6 20 mg in the MCMV group; P ¼ 0.001). However, there was no effect of inoculation with either Categorical data was analyzed by chi-square test. z Data is mean 6 SEM and was analyzed by one-way ANOVA followed by Sidak t-test. § Number of days between placing female with stud male and the detection of a vaginal plug. jj Pregnancy is defined as presence of viable fetuses at autopsy. a-c Different superscript letters denote significant differences between treatment groups (P , 0.05).
FIG. 1. The kinetics of infertility onset after immunization with rMCMV-mZP3. Mice were inoculated with MCMV control virus or rMCMV-mZP3. Females were placed together with stud males at Days 7, 14, or 21 after inoculation and were examined daily for vaginal plugs (n ¼ 9-10 mice per group). A sham-inoculated group was injected with PBS and placed with stud males 7 days later. On Day 17.5 pc, females were killed, and the number of viable fetuses was counted. Data were analyzed by one-way ANOVA, followed by Sidak t-test. Horizontal bars represent the mean values for each group. * P , 0.05 compared with PBS control group.
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virus on fetal weight in pregnancies established by mating at 14 or 21 days after inoculation (data not shown). Nor was there any effect of virus on placental weight or on fetal:placental weight ratio in any of the virus-inoculated groups at any time point (data not shown).
This shows that the progression of pregnancies established after virus inoculation was not adversely affected, other than a marginal reduction in fetal weights among mice in which pregnancies were conceived in the period soon after inoculation. The result is consistent with rMCMV-mZP3 immunization inhibiting reproductive events before embryo implantation but exerting little or no effect once pregnancy is established.
Effect of rMCMV-mZP3 on Ovulation and Early Embryo Development
The effect of rMCMV-mZP3 immunization on reproductive outcome and the time course of fertility decline were consistent with an anti-ZP3 immune response interfering with ovulation or with oocyte fertilization and early embryo development. To evaluate the effect of rMCMV-mZP3 immunization on ovulation and the events of early pregnancy, mice were injected with PBS or inoculated with rMCMV-mZP3 or rMCMV-OVA virus control and were placed with stud males 21 days later. On Day 3.5 pc, mice were autopsied, and reproductive tracts were flushed to evaluate the presence and number of developing embryos or unfertilized oocytes. The numbers of CL visible on ovaries were counted, and the plasma progesterone content was determined.
Consistent with the previous experiment, inoculation with rMCMV-mZP3 did not affect the proportion of mice that mated or the mating interval compared with mice inoculated with rMCMV-OVA virus control or PBS (Table 3) . Compared with the PBS control group, inoculation with control rMCMV-OVA had no effect on the proportion of mice with embryos, the number or stage of development of embryos, or the number of CL. In contrast, embryos were flushed from substantially fewer of the mice inoculated with rMCMV-mZP3 (nine of 10 and nine of 11 in the PBS and rMCMV-OVA groups, respectively, compared with two of 13 in the rMCMV-mZP3 group). Importantly, there was no increase in the number of unfertilized oocytes flushed from the reproductive tracts of rMCMVmZP3-inoculated mice, and although unfertilized oocytes could be found in the oviducts of nonpregnant mice in the control groups, this was not the case for mice inoculated with rMCMV-mZP3. Furthermore, the proportion of mice with CL and the number of CL per mouse were significantly decreased after rMCMV-mZP3 immunization (P , 0.05). Plasma progesterone content was reduced in the rMCMVmZP3-immunized mice (P ¼ 0.04) and correlated with CL number (R ¼ 0.85; P , 0.001).
The results of this experiment indicate that reproductive failure in mice immunized with rMCMV-mZP3 is primarily associated with ovulation of fewer oocytes. This results in diminished availability for fertilization and embryo development.
Effect of rMCMV-mZP3 Immunization on Ovarian Follicle Number
The reproductive outcomes of mice immunized with rMCMV-mZP3 suggested a predominant effect of a ZP3-specific immune response on ovarian function. To investigate the effect of rMCMV-mZP3 immunization on ovarian morphology, ovarian tissues recovered from mice inoculated 35 days earlier with rMCMV-mZP3 or MCMV control virus were sectioned and stained with hematoxylin and were compared with tissues from mice given PBS. Significant changes in architecture were evident in ovarian tissue from rMCMV-mZP3-inoculated mice (Fig. 2, A and B) , with extensive depletion of ovarian follicles. Under high power, the remaining identifiable follicles present in ovarian tissue from rMCMV-mZP3-inoculated mice seemed to have an abnormal follicular structure with irregular granulosa cell layers and fragmentation of the ZP (Fig. 2D) . In addition, stronger eosin staining resulted in a more pink appearance compared with sections from control mice (Fig. 2C) . Specifically, stromal cells frequently appeared to be larger with more intense eosin staining in the cytoplasm (Fig. 2D) , although this was not formally quantified.
To more precisely quantify the effect of rMCMV-mZP3 on ovarian follicle development, ovaries retrieved on Days 10, 15, 21, and 35 after inoculation were sectioned, and the numbers of primary, secondary, early antral, antral, and preovulatory follicles were quantified. There was no significant effect on the numbers of follicles at each developmental stage in mice inoculated at any time point with MCMV control virus compared with the PBS control group. In contrast, inoculation with rMCMV-mZP3 caused a substantial depletion in follicles at each developmental stage, with the more mature follicles showing the greatest and most rapid depletion. As early as Day 15 after inoculation, there was a 50% decline in the mean Categorical data was analyzed by chi-square test. z Number of days between placing female with stud male and the detection of a vaginal plug. § Data is mean 6 SEM and was analyzed by one-way ANOVA followed by Sidak t-test. jj Numbers are per female (pregnant and nonpregnant). # Pregnancy is defined as presence of developing embryos at autopsy. } Normal embryo development is defined as compacted morulla or blastocyst stage. a,b Different superscript letters denote significant differences between treatment groups (P , 0.05).
MECHANISM OF IMMUNOCONTRACEPTION WITH rMCMV-mZP3
number of preovulatory follicles compared with the control groups, although this did not reach statistical significance because of variation among animals. By Day 21, follicles at the early antral, antral, and preovulatory stages were completely absent from ovaries (Fig. 3, C-E) , and a substantial reduction in secondary follicles was also evident (Fig. 3B) . Primary follicles were also eventually depleted due to rMCMV-mZP3, but this was not evident until Day 35 after inoculation, when a 50% reduction was observed (P , 0.05) (Fig. 3A) .
Effect of rMCMV-mZP3 Immunization on Expression of Gdf9, Gja1, and Nobox
To further evaluate the effects of rMCMV-mZP3 on ovarian function, we measured the effect of virus inoculation on the expression of genes implicated in regulating ovarian follicle development and oocyte signaling. These included two oocytespecific genes, Gdf9, which encodes the oocyte signaling molecule GDF9 [25] , and Nobox, which encodes the homeobox gene product NOBOX [26] , as well as Gja1, which encodes the gap junction protein connexin43 (Cx43), expressed in granulosa cells throughout all stages of folliculogenesis [27, 28] . Inoculation with rMCMV-mZP3 decreased expression of Gdf 9 mRNA by 3-fold at Day 15 and by 10-fold at Day 21 after immunization compared with PBS and virus controls (P , 0.01) (Fig. 4A) . Nobox mRNA displayed a similar temporal pattern with a 2-fold decrease in expression at Day 10 and a 10-fold decrease at Day 21 (Fig. 4B) . In contrast to the oocyteproduced factors, there was a 2-fold increase in ovarian expression of Gja1 mRNA at Day 7 after inoculation with rMCMV-mZP3 compared with controls (P , 0.05), but this declined to 40% by Day 21 (P , 0.05) (Fig. 4C) .
Effect of rMCMV-mZP3 Immunization on Ovarian Leukocytes and CD4
þ and CD8 þ T Cells
The effect of rMCMV-mZP3 immunization on ovarian leukocyte parameters was examined in ovaries retrieved at Days 10, 21, and 35 after inoculation by immunohistochemical analysis using monoclonal antibodies reactive with all leukocytes (CD45) and T lymphocytes (CD4 and CD8). In ovaries of mice inoculated with MCMV control virus, CD45 þ leukocytes were localized predominantly within CL and were distributed throughout the interstitial stromal tissue and within the thecal layer of mature follicles. No leukocytes were evident in the granulosa layer of developing follicles (Fig. 5, A and D) . This pattern of distribution was indistinguishable from that seen in the PBS control group, and quantitative analysis confirmed that MCMV inoculation did not affect the abundance of leukocytes at any time point during the experiment (Fig. 6A) . In contrast, rMCMV-mZP3 inoculation elicited an inflammatory response in the ovary, with focal accumulation of infiltrating leukocytes within the stromal tissue (Fig. 5B) . CD45 þ cells were also located within the remaining identifiable follicles, where they were present within the granulosa cell layer (Fig. 5, E and F) , often in close proximity to the oocyte (Fig. 5G) . The increased abundance of inflammatory cells was evident from Day 10 after rMCMVmZP3 inoculation, and similar numbers of leukocytes were present at all time points examined, with 4-fold, 2-fold, and 6-fold increases at Days 10, 21, and 35 after inoculation, respectively (P , 0.05) (Fig. 6A) . Similar kinetics of recruitment and distribution patterns within the stromal tissue and follicles were observed for CD4 þ and CD8 þ T cells, with a sustained increase in lymphocyte numbers extending to Day 35 after inoculation (P , 0.05) (Fig. 6, B and C) .
DISCUSSION
Immunization with recombinant MCMV expressing mZP3 protein leads to complete and permanent infertility in BALB/c mice [14] and in outbred wild-derived mice [17] , indicating the potential utility of this viral vector for immunocontraceptive control of wild mice plagues [15] . The experiments described in this study were designed to investigate the mechanisms underpinning the infertility induced by rMCMV-mZP3, particularly to delineate between a causal pathway involving preconception or ovarian deficiency, as opposed to a periconceptual block in sperm-oocyte interaction at fertilization. Depletion of developing oocytes due to ovarian inflammatory pathology was identified as the major reproductive lesion. The fertility-inhibiting effects of immunization with rMCMV-mZP3 were dependent on expression of the mZP3 antigen in the immunizing virus, as no fertility loss was seen in mice inoculated with control virus comprising wild-type MCMV virus or recombinant MCMV virus encoding the irrelevant antigen ovalbumin. Indications of declining fertility were evident during the first 10 days after inoculation, and complete fertility loss was apparent in most mice by 14 days. All immunized mice were infertile by 3 wk after inoculation. At this time, infertility was associated with almost complete ablation of follicle development and oocyte ovulation, as indicated by histochemical examination of ovaries, as well as by the number of developing embryos or unfertilized oocytes recovered from reproductive tracts in mated mice.
Interference with fertilization of oocytes could not be ruled out as a contributing factor; however, our findings indicate that any fertility loss at this stage of the reproductive process is minimal and secondary to oocyte depletion. There was no evidence of fertilization failure without associated oocyte depletion; in the small proportion of mice in which ovulation remained partially intact at 3 wk after immunization, embryo development appeared normal, and surplus unfertilized oocytes were not found. That blastocyst-stage embryos were occasionally found in mice immunized 3 wk earlier with rMCMVmZP3, a time point when viable pregnancies were never observed, suggests that additional factors (including impaired   FIG. 3 . The effect of immunization with rMCMV-mZP3 on ovarian follicle development. Mice were inoculated with PBS, MCMV, or rMCMV-mZP3 at 6 wk of age. Ovaries were retrieved at Days 10, 15, 21, and 35 after inoculation and were sectioned every 21 lm for quantification of primary (A), secondary (B), early antral (C), antral (D), and preovulatory (E) follicles (n ¼ 5 mice per group). Data are given as mean 6 SEM and were analyzed by one-way ANOVA, followed by Sidak t-test. * P , 0.05 compared with PBS control group. Horizontal bars represent no detectable follicles.
MECHANISM OF IMMUNOCONTRACEPTION
Follicle depletion occurred in a time-dependent fashion during a 5-wk period after rMCMV-mZP3 immunization and affected all follicle development phases spanning primary through preovulatory stages, with faster loss evident in the more developed follicles compared with primary and secondary follicles. Normal follicle development was evident in mice inoculated with MCMV control virus, implicating an mZP3-specific immune response in the pathophysiological process.
Impaired fertility was preceded by inflammatory leukocyte infiltration into the ovary in immunized mice, suggesting an instrumental role for inflammatory cells in the subsequent ovarian follicle depletion. Leukocytes, predominantly CD4 þ and CD8 þ lymphocytes, accumulated within developing follicles from the earliest time point examined at Day 7 after rMCMV-mZP3 inoculation and remained consistently high during the 5-wk study. This result contrasts with our previous study [14] with rMCMV-mZP3, in which inflammatory cells were thought not to be involved in mediating follicle loss; however, the earlier observations were made in tissues without utilizing leukocyte-reactive antibodies to distinguish inflammatory cells. As with follicle depletion, the inflammatory response was dependent on virus expression of mZP3. Several possible mechanisms may contribute to inflammatory leukocyte recruitment into the ovaries, including accumulation of antigen-antibody complexes associated with endogenous ZP3 in follicles and subsequent activation of the complement cascade to generate chemotactic peptides.
Leukocytes, including T lymphocytes, are normally present in the ovary [29] and have prominent roles in follicle growth, development, atresia, and ovulation [30, 31] . Increases in their relative abundance, altered distribution, and activation phenotype are linked with naturally occurring autoimmune ovarian pathology in women [32, 33] and with immunization-or thymectomy-induced autoimmune disease in rodent models [11, [34] [35] [36] and in primates [37] . The mild focal oophoritis that we observed after immunization with rMCMV-mZP3 has histopathological features distinct from those of the extensive autoimmune oophoritis induced by immunization of B6AF1 mice with ZP3 peptide in adjuvant [11] . In that model, oophoritis can be transferred by antigen-reactive T cells and is characterized by multiple granulomas and heavy lymphocytic infiltrates in the interstitial space of the ovary [11] .
Our previous and ongoing studies in the rMCMV-mZP3 model indicate that immunization is associated with substantial production of anti-ZP3 antibodies in the peripheral blood and ovaries, with virus-reactive immunoglobulin evident by 7 days after inoculation and increasing in titre during the subsequent 5 wk [14, 17] . The results reported herein are consistent with a role for antibody and the cell-mediated immune response in mediating infertility, and findings from our experiments in progress suggest that antibody is essential for eliciting follicle loss (Lloyd and Shellam, unpublished (GDF9) (A), Nobox (B), and Gja1 (Cx43) (C). Messenger RNAs were quantified by real-time PCR in ovary tissue retrieved from mice at Days 10, 15, and 21 after PBS injection or inoculation with MCMV or rMCMVmZP3 (n ¼ 5 mice per group). Relative mRNA expression is calculated by normalizing data to Actb mRNA expression and is expressed as the percentage of the mean value in the saline (PBS)-inoculated animals within each group. Data are given as mean 6 SEM and were analyzed by Kruskal-Wallis test, followed by Mann Whitney U-test. * P , 0.05 compared with PBS control group. susceptibility of mature follicles to the autoimmune response might be explained by more immediate access and sequestration of antibody to the more highly vascularized peri-ovulatory and antral follicles compared with primary follicles, which have a limited vascular supply [38] . The substantially greater mass of ZP protein present in larger follicles would provide more antigenic epitopes and result in a higher load of antigenantibody complexes per oocyte. Accumulation of these complexes might cause oocyte death and follicle atresia by complement-mediated lysis of oocytes, by antibody-dependant cell-mediated cytotoxicity, or indirectly by inhibition of intraovarian communication networks on which oocyte maturation is critically dependent [39] . It seems likely that the cellmediated and antibody-mediated compartments of the ZP3 immune response are interrelated. In mice immunized with ZP3 peptide in adjuvant among mouse models [11, 36] , anti-ZP3 immunoglobulin seems to have a central role in inducing ovary-specific inflammation, and binding of antibody to the ZP is associated with redistribution of T cells from the ovarian interstitium and with degeneration of follicles into the growing and mature follicles [40] .
Ovarian function is dependent on cell-to-cell communication between the oocyte and surrounding granulosa and thecal cells [39] . This communication is mediated by specific oocytederived factors and by gap junctions that are present between neighboring granulosa cells and between granulosa cells and the oocyte. Immunization with rMCMV-mZP3 exerted a substantial effect on expression of oocyte-signaling genes encoding NOBOX and GDF9 (Gdf 9) and the gap junction gene encoding Cx43 (Gja1). Each of these factors is essential for normal follicle development. NOBOX is a specific oocytederived factor expressed in primordial and growing follicles, and a null mutation in Nobox leads to postnatal oocyte loss and inhibits oocyte and follicle growth beyond the primordial stage [26] . Gdf 9 is first expressed in primary follicles and persists until ovulation [25] . GDF9 deficiency results in a blocking of folliculogenesis past the primary stage and inhibits granulosa cell proliferation [41] . Gja1 is expressed in the ovary from early fetal development [42] and is the predominant connexin in developing follicles, where it localizes to junctions between neighboring granulosa cells [28, 42] . In mice, targeted disruption of the Gja1 gene results in postnatal death due to impaired cardiac function [43] . Using an organ culture technique to examine postnatal folliculogenesis in Gja1-null mutant mice, Cx43 was found to be necessary for follicles to progress past the primary stage [44] .
The time course of altered Gdf9 and Gja1 gene expression after inoculation with rMCMV-mZP3 closely mimicked the þ cells were distributed throughout the stromal tissue and CL (A) but were excluded from the granulosa layers of antral follicles (D, large arrow) and pre-antral follicles (D, small arrows). In ovaries of mice inoculated with rMCMV-mZP3, CD45
þ cells were more abundant in stromal tissue (B) and were present in the granulosa cell layers, preantral follicles, and secondary follicles (E, large arrows), where breakdown of the ZP and surrounding granulosa layers was evident (F, small arrow). CD45 þ cells were sometimes evident in the granulosa layer adjacent to oocytes, particularly in primary follicles (G, small arrows). C) Ovarian tissue of an MCMV-inoculated mouse stained with an irrelevant primary antibody. Photomicrographs are representative of immunohistochemistry in tissue from n ¼ 5 mice per group. CL, corpus luteum; St, stromal tissue. Bars ¼ 200 lm (A-C), 100 lm (D and E), and 50 lm (F and G).
kinetics of follicle loss measured by histological analysis, with reduction to less than 20% of mRNA expression in control groups by Day 15 after inoculation. This is consistent with the reduced expression of these genes, reflecting the substantial oocyte death that occurs during this period, and indicates that these genes provide a surrogate molecular measure of follicle number that may have practical utility as an alternative to counting follicle numbers in future studies.
The effect of rMCMV-mZP3 immunization on expression of Gja1 mRNA encoding Cx43 was somewhat different, with significant upregulation in expression at Day 10 after inoculation before decline at later time points. Expression of Gja1 has been shown to increase in association with antiapoptotic responses in rat granulosa cells [45] , and increased expression may be a response to follicle damage early in the autoimmune pathology. The reduced expression of Gja1 mRNA by Day 15 after inoculation is consistent with the decline in granulosa cell abundance with progressive follicle loss, indicating that this gene provides a further molecular index of follicle number.
Immunization with rMCMV-mZP3 and the resultant ovarian pathology did not prevent progression of the normal ovarian cycle in terms of its effect on reproductive behavior. Female mice continued to be receptive to mating and exhibited the normal interval between placement with males and mating, at least until Day 21 after inoculation. This is consistent with our earlier observations of normal occurrence and duration of the estrous cycle measured by vaginal cell morphology during the period after virus inoculation [14] . The ovaries of immunized mice must continue to synthesize sufficient estrogen and progesterone to maintain libido and allow mating behavior [46] . We have not examined the cycling activity of mice beyond the first few months after immunization, so whether sufficient ovarian hormone synthesis is maintained to support cycling beyond this time is unknown. Maintenance of overtly normal mating behavior in mice after rMCMV-mZP3 immunization would be a benefit in terms of the use of the virus for immunocontraception in wild mouse populations, particularly in facilitating dissemination, as MCMV is believed to be transmitted by saliva or by sexual contact [47] . Furthermore, maintaining sexual receptivity in sterile females would be expected to reduce the effect of any adverse effects of immunocontraception on mating dynamics at the population level and would prevent male competition for a diminishing pool of fertile females.
Murine cytomegalovirus infection has previously been shown to affect fetal development in mice, with fetal death and growth restriction in surviving fetuses resulting from virus inoculation during pregnancy [48, 49] . Maternal immunopathology resulting from the use of a virulent preparation of MCMV was considered a major factor [49] . Comparison of reproductive performance in mice infected with MCMV vs. PBS control mice did not reveal any substantial effect of MCMV infection on fertility or fecundity in the present study. However, fetal growth restriction was evident in mice inoculated with MCMV 7 days before mating, with a 10% þ , CD4 þ , and CD8 þ leukocyte populations. Leukocytes were quantified after immunohistochemical staining with monoclonal antibody reactive with all leukocytes (CD45 þ ) (A), CD8 þ T cells (B), or CD4 þ T cells (C) in ovary tissue retrieved from mice at Days 10, 21, and 35 after inoculation with MCMV, rMCMV-mZP3, or PBS (n ¼ 5 mice per group). Data are expressed as mean 6 SEM positivity and were analyzed by one-way ANOVA, followed by Sidak t-test. * P , 0.05 compared with PBS control group. reduction in fetal weight in groups infected with MCMV control virus or with rMCMV-mZP3. Fetal growth restriction was not evident in mice mated at later time points after inoculation. The effect of MCMV is not likely to be due to fetal infection, as placental transfer does not occur in immunocompetent mice and fetal infection is rarely observed [18, 50] . The fetal growth restriction seen in pregnancies conceived during the most active phase of viral replication might be linked to induction of antiviral immunity. Cell-mediated (Th1) immunity is required to control MCMV replication [51] , and mediators of inflammation and Th1 immunity have adverse effects on fetal growth [52] . A similar effect is observed in pregnant C57BL/6 mice infected with the intracellular parasite Leishmania, which activates a strong Th1 host response [53] , or in mice with a genetic predisposition to Th1 and inflammatory skewing due to interleukin 10 deficiency [54] . The lack of any adverse effect on fetal growth attributable to ZP3-specific immunity is important in view of concerns for the health of offspring of animals previously vaccinated against conception [55] .
In summary, these results provide compelling evidence that rMCMV-mZP3 inoculation elicits infertility in BALB/c mice predominantly through induction of autoimmune follicle depletion in the ovary. This study advances our understanding of the mechanisms through which rMCMV-mZP3 exerts immunocontraceptive activity and adds to the knowledge base required to justify serious consideration of using a disseminating virus for biological control of mice or other pest animal species. Several questions remain, including the precise contribution of cell-mediated vs. antibody-mediated immunity, and the strain-specific effects of vaccination [17] raises the question of effects of major histocompatibility complex haplotype and polymorphisms in other immune response genes in outbred mouse populations. Additional research is required to address the relative roles of virally encoded mZP3 vs. endogenous ZP3 in the activation and maintenance of the autoimmune pathology induced by rMCMV-mZP3, as well as the pathway by which viral expression of mZP3 overrides the protection exerted by regulatory T cells that mediate immune tolerance to this molecule [56] . The capacity of rMCMV-mZP3 to disrupt endogenous immune tolerance to ''self'' ZP3 highlights the potential of this model system for investigating the etiology of human autoimmune ovarian disease. The model might also be relevant to ovarian pathologies suspected of having an autoimmune component, including premature menopause [57] and polycystic ovarian syndrome [58, 59] , in which imbalances in regulatory vs. immune T lymphocytes are implicated in contributing to ovarian dysfunction [56] .
